Last reviewed · How we verify
NCT03582423
Acupuncture for Chemotherapy-induced Peripheral Neuropathy
NA trial testing electro-acupuncture in Chemotherapy Induced Peripheral Neuropathy in 60 participants. Completed in 30 September 2020.
31 August 2020
Quick facts
| Lead sponsor | Hong Kong Baptist University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 22 October 2018 |
| Primary completion | 31 August 2020 |
| Estimated completion | 30 September 2020 |
| Sites | 1 location across Hong Kong |
Drugs / interventions tested
- electro-acupuncture
Conditions studied
- Chemotherapy Induced Peripheral Neuropathy — all drugs for Chemotherapy Induced Peripheral Neuropathy →
Sponsor
Hong Kong Baptist University
Who can join
18 and older, any sex, with Chemotherapy Induced Peripheral Neuropathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this study, a 24-week, single blinded, randomized controlled clinical trial will be conducted to examine the efficacy and safety of acupuncture for Chemotherapy Induced Peripheral Neuropathy (CIPN) in colorectal cancer patients in Hong Kong.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Integrated Medicine for Chemotherapy-Induced Peripheral Neuropathy.
Tsai CH, Lin YH, Li YS, Ho TL, et al · · 2021 · cited 12× · PMID 34502166 · DOI 10.3390/ijms22179257 -
Efficacy and safety of electroacupuncture for oxaliplatin-induced peripheral neuropathy in colorectal cancer patients: a single-blinded, randomized, sham-controlled trial.
Chan K, Lui L, Lam Y, Yu K, et al · · 2023 · cited 10× · PMID 36325677 · DOI 10.1177/09645284221125421 -
Emerging Approaches for the Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN): Therapeutic Potential of the C5a/C5aR Axis.
Spera MC, Cesta MC, Zippoli M, Varrassi G, et al · · 2022 · cited 10× · PMID 36098939 · DOI 10.1007/s40122-022-00431-8 -
The efficacy and safety of electro-acupuncture for alleviating chemotherapy-induced peripheral neuropathy in patients with coloreactal cancer: study protocol for a single-blinded, randomized sham-controlled trial.
Chan K, Lui L, Yu K, Lau K, et al · · 2020 · cited 10× · PMID 31918748 · DOI 10.1186/s13063-019-3972-5
Verify or expand the search:
- PubMed search for NCT03582423
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of electro-acupuncture
Trials testing the same drug.
- NCT04211324 — Acute Salivary Flow Rate Response to Transcutaneous Electrical Nerve Stimulation Versus Electro-acupuncture · unknown
- NCT05367986 — Electro-acupuncture at Zusanli, Qihai, and Guanyuan Acupoints Regulate Immune Function in Patients With Sepsis · NA · completed
Other Hong Kong Baptist University trials
Trials by the same sponsor.
- NCT07469423 — Continuous Music and Sports Training for Children · NA · not yet recruiting
- NCT07411456 — School-based Active Play Intervention to Facilitate Movement Behaviours and Fundamental Movement Skills in Primary Schoo · NA · not yet recruiting
- NCT07243223 — Urinary Incontinence in Older Hong Kong Women: A Cross-sectional Study · not yet recruiting
- NCT07056179 — Brief Behavioral Intervention to Maintain Sleep Regularity in Young Adults Over the Christmas Break · NA · not yet recruiting
- NCT06741878 — A Biopsychosocial Approach to Improving Multidimensional Frailty Status in Community-Dwelling Older Adults · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03582423 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hong Kong Baptist University
- Last refreshed: 9 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03582423.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing